POEM vs Heller myotomy with Dor fundoplication for achalasia
Official title: Peroral Endoscopic Myotomy (POEM) Versus Laparoscopic Heller Cardiomyotomy With Dor Fundoplication for the Treatment of Oesophageal Achalasia: A Randomized Controlled Trial
Run by Minia University · NCT07814027 · Data updated 2026-11-12
This trial tests POEM against laparoscopic Heller myotomy with Dor fundoplication to see which procedure better helps adults with achalasia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 220 (estimated) |
| Sponsor | Minia University Academic / other |
| Locations | 1 site (Minya, Minya Governorate) |
| Status | Recruiting |
| Started | September 20, 2026 |
| Main results expected | September 20, 2028 |
| Study ends | December 20, 2028 |
| Registry record updated | September 22, 2026 |
| Trial ID | NCT07814027 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18–75 with a new diagnosis of primary achalasia confirmed by high-resolution manometry and no prior definitive therapy.
✕Probably not a fit
Patients with previous esophageal surgeries, secondary/pseudoachalasia, or contraindications to anesthesia may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with newly diagnosed primary achalasia are randomized to receive either peroral endoscopic myotomy (POEM) or laparoscopic Heller myotomy with Dor fundoplication. The study compares symptom relief and outcomes related to esophageal function, reflux, and safety over follow-up. Procedures aim to reduce the obstruction at the esophagogastric junction, but POEM may have a higher risk of reflux while Heller with Dor includes a built-in anti-reflux component. The trial builds on previous evidence suggesting similar short- to medium-term success, while addressing durability and reflux in broader clinical settings.
Why it matters
Potential benefit: If successful, the trial could clarify which procedure offers better symptom relief with acceptable reflux risk for achalasia patients.
How similar studies have gone: Earlier randomized studies showed POEM and Heller with Dor have similar short- to medium-term success, but reflux risk differs between approaches.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 to 75 years. * New diagnosis of primary achalasia confirmed by high-resolution manometry according to the Chicago Classification version 4.0 (elevated median integrated relaxation pressure with 100% failed peristalsis), of any subtype (I, II or III). * Eckardt symptom score of 4 or more at baseline. * Upper endoscopy excluding mechanical obstruction, malignancy and pseudoachalasia. * Treatment-naive with respect to definitive therapy (no prior Heller myotomy, prior POEM or prior pneumatic dilation). Prior botulinum-toxin injection is permitted if administered at least 6 months before enrollment. * Fit for general anesthesia (American Society of Anesthesiologists physical status I to III). * Able to provide written informed consent and to comply with the follow-up schedule. Exclusion Criteria: * Prior esophageal or gastric surgery, prior myotomy (surgical or endoscopic), or prior pneumatic dilation. * Secondary (pseudo-) achalasia, suspected or confirmed esophagogastric malignancy, or eosinophilic esophagitis. * Sigmoid or end-stage megaesophagus (tortuous, dilated greater than 7 cm) considered unsuitable for myotomy. * Severe esophageal varices, significant coagulopathy, or therapy with anticoagulants that cannot be safely interrupted. * Significant cardiopulmonary disease precluding general anesthesia or capnoperitoneum / capnomediastinum. * Pregnancy or breastfeeding. * Body mass index below 18.5 kg/m2 with severe malnutrition requiring prior nutritional optimization (may be re-screened after optimization). * Inability to provide informed consent or anticipated non-compliance with follow-up.
Where it's running
-
Minia University Hospitals - Department of Surgery, Faculty of Medicine, Minia University
Minya, Minya Governorate, Egypt Recruiting
Study contacts
- Principal investigator: Saleh K Saleh, MD — Minia University
- Study coordinator: Saleh Khairy K Saleh, MD
- Email: salehkhairy@mu.edu.eg
- Phone: 01201765401
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Assessing esophageal motility after partial fundoplication for reflux
This study is testing how a surgery for acid reflux affects the way food moves through the esophagus in patients who have had or will have the procedure.
-
Impact of Patient Position on EndoFLIP Measurements in Kids and Young Adults
This study tests whether EndoFLIP measurements differ when patients are in the supine versus left-side position during the procedure.
-
Speedboat UltraSlim™ for POEM in adults with achalasia and other esophageal motility disorders.
This registry will see if using the Speedboat UltraSlim™ device for POEM is safe and effective for adults with achalasia or other esophageal motility disorders.
-
Hydrotalcite (Talcid) for relief of rebound acid symptoms after stopping long-term PPI therapy
We are trying hydrotalcite (Talcid) to see if it relieves rebound acid symptoms in adults who have stopped long-term PPI treatment.
-
Comparing Botox and surgery for stomach drainage during esophagectomy
This study is testing whether Botox injections can help people who have had esophagus surgery manage delayed stomach emptying just as well as surgery can.
-
Detecting Barrett's Esophagus in Patients Without GERD Symptoms
This study is testing a new way to find Barrett's esophagus in people who don’t have GERD symptoms by using a simple capsule test instead of the usual endoscopy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.